Concepedia

Publication | Open Access

Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma

DOIFull Paper Access

83

Citations

29

References

2005

Year

Geoffrey Chong, Fook Thean Lee, Wendie Hopkins, Niall C. Tebbutt, Jonathan Cebon, Angela J. Mountain, Bridget Chappell, Anthony T. Papenfuss, Paul Schleyer, Udo Paul,
Clinical Cancer Research

Abstract

Radioimmunotherapy using 131I-huA33 shows promise in targeting colorectal tumors, and is deliverable at a maximum tolerated dose of 40 mCi/m2. Further studies of 131I-huA33 in combination with chemotherapy are planned.

References

YearCitations

Page 1